image

The best stocks to buy since 1993

Latest issue now available

McBride - Private label volumes up and contract manufacturing recovers

September 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MCB
  • Price:
  • 125.5p
Ahead of reporting on 17 September, McBride confirmed full year profit will be in line with recently upgraded expectations (Investec forecasts £54.5m pretax profit/eps of 22.3p for the year ended June). Whilst private label volume growth was +7.2%, it’s moderating from the 9 month figure. However, McBride has also reported very strong growth in contract manufacturing volumes in Q4 having won a substantial new contract. Total volume growth was 5.7% and drove sales up 6.2% on a constant currency basis. Net debt has fallen by £35m from the FY23 figure to £131.5m. Investec sees a slight currency headwind and forecasts £48m pretax profit /eps of 19.6p this year. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe